Moreover, genome-wide association studies have pinpointed several genetic risk factors for sporadic AD, consistently highlighting the robust association between AD and certain variants of apolipoprotein E (APOE) and triggering receptor expressed on myeloid cells 2 (TREM2) among others [18–21]. The gene discussed is TREM2; the disease is Alzheimer disease.